News

GPEx technology is used to develop mammalian cell line and create stable, high expression cell lines that will speed biologics drug development. TBI is a biologics supplier and

The agreement is also extended to include another company – Ortho-Clinical Diagnostics. As per the agreement, the three companies will partner to develop and to apply regulatory approvals

Christely has collaborated with AstraZeneca, Pfizer, Dainippon Sumitomo, multiple financing transactions as well as M&A, divestments and strategic restructurings. In 2001 he served Atugen as chief financial officer

Glucarpidase is an investigational product which is indicated for the rapid and sustained reduction of toxic methotrexate levels due to impaired renal function. Additionally, the agency has granted

The drug is being distributed by Ziwell Medical in Singapore. Following HSA’s decision, all sales and distribution of Zerin tablets have been discontinued from the public healthcare institutions,

The drugs which will be discovered will target the diseases that interest to Boehringer. As per the terms of the agreement, Nuevolution is responsible to get an upfront

The trial aims to evaluate the the safety and tolerability of intravenous ME-143 in patients with refractory solid tumors. The Phase I trial expects to recruit around 24

Under the deal, the companies will initially work on chemical compounds that target TDP-43, a protein that is a prime suspect in the disease. With their three year

The company is developing NBI-98854 to address the unmet medical needs of patients suffering from tardive dyskinesia (TD). The trial aims to evaluate once-daily NBI-98854 (12.5mg and 50mg)